Provided by Tiger Fintech (Singapore) Pte. Ltd.

Cue Biopharma, Inc.

0.8165
-0.0038-0.46%
Volume:98.44K
Turnover:82.03K
Market Cap:61.52M
PE:-1.26
High:0.9000
Open:0.8300
Low:0.8064
Close:0.8203
Loading ...

Cue Biopharma Reports New Complete Response and Confirmed 50% Overall Response Rate in Ongoing Phase 1 Trial of CUE-101 and Pembrolizumab in Recurrent/Metastatic HPV+ Head and Neck Cancer

GlobeNewswire
·
16 Jul

Cue Biopharma announces presentation of new CUE-101 data

TIPRANKS
·
02 Jul

BRIEF-Cue Biopharma Updates on CUE-101 at DAVA 4th Hawaii Summit

Reuters
·
02 Jul

Cue Biopharma Receives FDA Feedback for Trial Design of Drug Candidate to Treat Autoimmune Diseases

MT Newswires Live
·
25 Jun

Cue Biopharma CFO Kerri-Ann Millar to Depart

MT Newswires Live
·
11 Jun

BRIEF-Cue Biopharma CEO Daniel Passeri To Serve As Interim CFO

Reuters
·
11 Jun

Cue Biopharma Inc. Files Initial Beneficial Ownership Statement for Director Jill Marie Broadfoot

Reuters
·
07 Jun

Cue Biopharma Inc reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
14 May

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
13 May

Cue Biopharma Q1 EPS $(0.17) Misses $(0.15) Estimate, Sales $421.00K Miss $1.27M Estimate

Benzinga
·
13 May

Cue Biopharma Inc. Reports Q1 2025 Results: Revenue Falls to $0.4M, Net Loss at $12.3M, EPS at $(0.17)

Reuters
·
13 May

Cue Biopharma Inc expected to post a loss of 15 cents a share - Earnings Preview

Reuters
·
09 May

Cue Biopharma to Participate in Fireside Chat at the Citizens Life Sciences Conference

GlobeNewswire
·
05 May

Cue Biopharma Inc expected to post a loss of 15 cents a share - Earnings Preview

Reuters
·
05 May

Will Cue Biopharma, Inc. (CUE) Report Negative Q1 Earnings? What You Should Know

Zacks
·
01 May

BRIEF-Cue Biopharma Prices Common Stock And Warrants At $0.79 Per Share; Pre-Funded Warrants At $0.789

Reuters
·
15 Apr

BRIEF-Boehringer Ingelheim, Cue Biopharma Partner To Develop Autoimmune And Inflammatory Disease Treatments

Reuters
·
15 Apr

Cue Biopharma Starts Underwritten Equity Offering

MT Newswires Live
·
15 Apr

Cue Biopharma announces common stock, warrant offering, no amount given

TIPRANKS
·
15 Apr

Cue Biopharma receives $12M upfront in CUE-501 license pact

TIPRANKS
·
15 Apr